Ronald Linnartz
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Advanced Breast Cancer Therapies
- Oncology top 10%
- Bone health and treatments
- HER2/EGFR in Cancer Research
Papers in
-
- Fibroblast Growth Factor Research 4
- PI3K/AKT/mTOR signaling in cancer 3
- Cancer therapeutics and mechanisms 2
- Melanoma and MAPK Pathways 2
- Oncology 12
- HER2/EGFR in Cancer Research 2
- Co-authors
- Dennis J. Slamon (12 shared papers)Yong-Jiang Hei (1 shared paper)David L. Bilhartz (1 shared paper)Arif Hussain (1 shared paper)Norman R. Zinner (1 shared paper)Eric J. Small (1 shared paper)Fairooz F. Kabbinavar (1 shared paper)Ming Zheng (1 shared paper)
- Journals
- Cancer Research (12 papers)Journal of Clinical Oncology (2 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesSwitzerlandBelgium
In The Last Decade
Ronald Linnartz
22 papers receiving 767 citations
Peers
Comparison fields: 5 of 60
- Pulmonary and Respiratory Medicine 530
- Oncology 368
- Cancer Research 183
- Radiology, Nuclear Medicine and Imaging 189
- Genetics 61
Countries citing papers authored by Ronald Linnartz
This map shows the geographic impact of Ronald Linnartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Linnartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Linnartz more than expected).
Fields of papers citing papers by Ronald Linnartz
This network shows the impact of papers produced by Ronald Linnartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Linnartz. The network helps show where Ronald Linnartz may publish in the future.
Co-authors
The 25 scholars most cited alongside Ronald Linnartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 377 | |
| 2 | 2014 | 93 | |
| 3 | 2020 | 87 | |
| 4 | 2011 | 48 | |
| 5 | 2015 | 46 | |
| 6 | 2014 | 42 | |
| 7 | 2014 | 38 | |
| 8 | 2000 | 25 | |
| 9 | 2011 | 5 | |
| 10 | 2017 | 4 | |
| 11 | 2019 | 3 | |
| 12 | 2020 | 3 | |
| 13 | 2011 | 2 | |
| 14 | 2004 | 2 | |
| 15 | 2011 | 2 | |
| 16 | 2012 | 2 | |
| 17 | 2009 | 2 | |
| 18 | 2015 | 1 | |
| 19 | 2013 | 1 | |
| 20 | 2019 | 1 |
About Ronald Linnartz
Ronald Linnartz is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 22 papers that have together received 786 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), Fibroblast Growth Factor Research (4 papers), Lung Cancer Treatments and Mutations (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer therapeutics and mechanisms (2 papers), Melanoma and MAPK Pathways (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (530 citations), Oncology (368 citations), Cancer Research (183 citations), Radiology, Nuclear Medicine and Imaging (189 citations) and Genetics (61 citations). Ronald Linnartz has collaborated with scholars based in United States, Switzerland and Belgium. Frequent co-authors include Dennis J. Slamon, Yong-Jiang Hei, David L. Bilhartz, Arif Hussain, Norman R. Zinner, Eric J. Small, Fairooz F. Kabbinavar, Ming Zheng, Fred Saad and R. Nevin Murray. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Molecular Cancer Therapeutics, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.